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Glutamate and the N-methyl-D-aspartate receptor ligand D-serine
are putative gliotransmitters. Here, we show by immunogold
cytochemistry of the adult hippocampus that glutamate and D-
serine accumulate in synaptic-like microvesicles (SLMVs) in the
perisynaptic processes of astrocytes. The estimated concentration
of fixed glutamate in the astrocytic SLMVs is comparable to that in
synaptic vesicles of excitatory nerve terminals (~45 and ~55 mM,
respectively), whereas the D-serine level is about 6 mM. The
vesicles are organized in small spaced clusters located near the
astrocytic plasma membrane. Endoplasmic reticulum is regularly
found in close vicinity to SLMVs, suggesting that astrocytes contain
functional nanodomains, where a local Ca21 increase can trigger
release of glutamate and/or D-serine.
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Introduction
Astrocytes contain a variety of transmitter receptors enabling
them to respond to neuronal activity by increasing the
intracellular Ca2
+
concentration ([Ca2
+
]i) (Dani et al. 1992;
Pasti et al. 1997; Wang et al. 2006). Such a [Ca2
+
]i increase
triggers release of a variety of signaling substances, including
glutamate, purines, D-serine, eicosanoids, and tumor necrosis
factor alpha (TNF-a) (Volterra and Meldolesi 2005). Evidence
suggests that glutamate and D-serine are released from
astrocytes via Ca2
+
-dependent exocytosis (for review, see Oliet
and Mothet 2008; Santello and Volterra 2009). The existence of
a tightly regulated mechanism of glutamate release in
astrocytes (Bezzi et al. 2004; Marchaland et al. 2008) is
consistent with data indicating that these cells play rapid and
precise roles in neuromodulation (Jourdain et al. 2007; Perea
and Araque 2007; Santello et al. 2011) and neurovascular
coupling (Winship et al. 2007; Schummers et al. 2008).
However, conﬂicting data have been presented (Fiacco et al.
2007; Li et al. 2008; Petravicz et al. 2008; Agulhon et al. 2010),
questioning the existence of rapid gliotransmitter exocytosis
from astrocytes serving physiological neuromodulation (Agul-
hon et al. 2008; Fiacco et al. 2009). To resolve this controversy,
there is a need to provide direct in situ evidence of glutamate-
containing vesicles in adult astrocytes. As for D-serine, data
suggest that this amino acid is released from astrocytes to act as
an endogenous N-methyl-D-aspartate (NMDA) receptor co-
agonist at central synapses (Panatier et al. 2006; Oliet and
Mothet 2008, but see Rosenberg et al. 2010). Moreover,
astrocyte D-serine was recently found to be essential for the
establishment of NMDA receptor--dependent long-term poten-
tiation (LTP) in the hippocampus (Henneberger et al. 2010).
However, it is not known whether D-serine is stored in vesicles
of astrocytes in situ, although in vitro evidence indicates that D-
serine and glutamate could be contained in similar vesicular
organelles (Martineau et al. 2008). Here, we address these
questions by using high-resolution quantitative immunogold
cytochemistry with speciﬁc antibodies to glutamate and D-
serine.
Materials and Methods
Perfusion Fixation and Antibody Speciﬁcity
Rats derived from the Wistar strain (4--5 weeks) were anesthetized with
pentobarbital (100 mg/kg) before ﬁxation through transcardiac perfu-
sion (50 mL/min for 15 min) with a mixture of 4% formaldehyde and
0.5% glutaraldehyde (glutamate/EEAT2, glutamate/VGLUT1, and D-
serine/VGLUT1 immunocytochemistry, n = 3 rats) or 2.5% glutaralde-
hyde and 1% formaldehyde (D-serine/EAAT2 and glutamate/D-serine
immunocytochemistry, n = 3 rats or morphological analysis, n = 3 rats).
For morphological analysis, the ﬁxed tissues were treated with 1%
osmium tetroxide before embedding in Durcupan. For immunogold
analysis, specimens of hippocampus were cryoprotected with increasing
concentrations of glycerol (10%, 20%, and 30%) and embedded in
Lowicryl HM20 according to a freeze substitution protocol. Ultrathin
sections (50--100 nm) were subjected to either morphological analysis or
postembedding immunogold cytochemistry (Bergersen et al. 2008) using
the following primary antibodies: rabbit anti-glutamate (no 607, dilution
1:30 000), rabbit anti-D-serine (no 21 236, dilution 1:2000), rabbit anti-
EAAT2 (a mixture of anti-B12, 10 lg/mL and anti-B493, 5 lg/mL), goat
anti-EAAT2 antibodies (2 lg/mL, Santa Cruz Biotechnology, Santa Cruz,
CA), guinea pig anti-VGLUT1 antibodies (dilution 1:1000 Synaptic
Systems), mouse caveolin-1 antibodies (dilution 1:300, BD Biosciences),
rabbit anti-calreticulin antibodies (dilution 1:300, AbCam), and mouse
anti-glutamine syntehase antibodies (dilution 1:100, BD Biosciences). The
anti-glutamate and anti-D-serine antibodies were raised essentially as ﬁrst
described (Storm-Mathisen et al. 1983). The 607 glutamate antiserum has
been proven to be speciﬁc through extensive characterization (Broman
et al. 1993; Gundersen et al. 1998) and was used with the addition of 0.2
mM glutaraldehyde- and formaldehyde-treated aspartate and glutamine.
The 21 236 D-serine antiserum has not been characterized previously. To
test the D-serine antibodies, test specimens (Ottersen and Storm-
Mathisen 1984) were made by spotting conjugates of about 50 different
amino acids and peptides endogenous to the brain, linked to brain
proteins by glutaraldehyde/formaldehyde onto cellulose nitrate/acetate
ﬁlters. The test ﬁlters were processed with the D-serine antibodies
according to a 3 layer peroxidase--antiperoxidase method. The tested
compounds were L- and D-serine, L- and D-homocysteate, D-cysteine,
DL-homocysteine, L-citrulline, reduced glutathione, b-alanine, D-aspartate,
hypotaurine, L-cystine, L-isoleucine, D-arginine, L-methionine, glutamyl-
glutamate, D-leucine, L-phenylalanine, L-serine, null (no amino acid),
L-leucine, L-proline, c-aminobutyric acid (GABA), L-glutamate, L-taurine,
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glycine, L-aspartate, L-glutamine, epinephrine, norepinephrine, phosphoe-
tanolamine, 3-aminopropane sulphonate (homotaurine), L-homocysteine
sulphinate, L-a-alanine, L-valine, L-tryptophane, L-threonine, L-cysteine,
L-tyrosine, L-asparagine, L-lysine, L-arginine, L-histidine, L-cysteate, gluta-
myltaurine, cysteine sulphinate, N-acetylaspartate, oxidized glutathione, L-
S-sulpho-cysteine, leu-enkephalin, and met-enkephalin. There was a slight
cross-reactivity against L-serine as well as against L-cysteine, which
disappeared when the serum was preabsorbed with soluble glutaralde-
hyde/formaldehyde complexes of these amino acids. In each immunogold
experiment, ultrathin test sections (Ottersen 1987) were processed along
with the hippocampal sections, ascertaining the speciﬁcity of the labeling
produced. The test sections were made of conjugates of different amino
acids linked to brain macromolecules by glutaraldehyde--formaldehyde,
which were freeze dried and embedded in epoxy resin (Ottersen 1987).
In particular, the D-serine antibodies were tested against 12 different
amino acids (D-serine, L-cystein, D-cystein, L-valine, a-alanine, glycine,
L-serine, L-glutamate, L-aspartate, glutamine, GABA, and taurine) of which
only the conjugate-containing D-serine was labeled (see Supplementary
Fig. 1).
We also tested the rabbit 87554 D-serine antiserum, which showed
quite a strong labeling of the D-serine conjugate but also an additional
weak labeling of all the other amino acid conjugates in the electron
microscopic ‘‘test sandwich.’’ Thus, in this project, we only used the
21 236 D-serine antiserum. In the course of the experiments, we tested
2 commercial rabbit anti-D-serine antisera, one from AbCam (ab 6572;
Cambridge, UK) and one from Advanced Targeting Systems (AB-T048;
San Diego, CA). Both antibodies produced a strong cross-reactivity
against the GABA conjugate in the ultrathin test sections as well as
strong labeling of terminals forming symmetrical synapses in the
ultrathin tissue sections (not shown). As an extra negative control test,
the glutamate and D-serine immunoreactivities of tissue and test
sections were blocked by adding 0.3 mM aldehyde-treated glutamate
and D-serine to the respective antisera. The rabbit EAAT2 antisera (anti-
B12 and anti-B493) have been extensively characterized (Lehre et al.
1995; Beckstrøm et al. 1999). When tested on western blots of
hippocampal homogenates, the VGLUT1 antibodies produced a single
band with an appropriate molecular weight of about 65 kDa. In
a parallel study, the VGLUT1 antibodies produced strong astrocytic
labeling in wild type and weak labeling in VGLUT1 knockout
hippocampus (L Ormel, LH Bergersen, V Gundersen, unpublished
data). According to the manufacturer, the caveolin-1, calreticulin, and
glutamine synthetase antibodies are speciﬁc and give one single band
with appropriate molecular weights on western blots of brain tissue.
The rabbit glutamate, rabbit D-serine, and rabbit calreticulin primary
antibodies were visualized with goat anti-rabbit (10 nm gold particles,
BBI, UK), the rabbit EAAT2 antibodies with goat anti-rabbit (15 nm gold
particles, BBI), the goat EAAT2 antibodies with donkey anti-goat (15 nm
gold particles, Aurion, the Netherlands), the guinea pig VGLUT1
antibodies with goat anti-guinea pig (15 nm gold particles, BBI), the
mouse glutamine synthetase antibodies with goat anti-mouse (15 nm
gold particles, BBI), and the mouse caveolin-1 antibodies with goat anti-
mouse (10 nm gold particles, BBI) secondary antibodies. In double
labeling immunogold experiments, in which the rabbit EAAT2 anti-
bodies were used, glutamate- or D-serine--labeled sections were treated
with formaldehyde vapor (70 C, 1 h) to inactivate unoccupied binding
sites on the primary rabbit immunoglobulins, before labeling with the
rabbit anti-EAAT2 antibodies. The same approach was used in double
labeling for D-serine and glutamate (visualized with the 10 and 15 nm
coupled goat anti-rabbit secondary antibodies, respectively). The rabbit
anti-EAAT2 and goat EAAT2 antibodies showed similar immunogold
labeling patterns. In the quantitative analysis (see below), we used
sections that were labeled with the glutamate or D-serine antibodies in
the ﬁrst step and the rabbit EAAT2 antibodies in the second step.
Morphological and Quantitative Immunogold Analysis
Electron micrographs of the ultrathin tissue sections were randomly
taken (with a Philips CM 10 or a Tecnai 12 electron microscope) in the
outer two-thirds of the dentate molecular layers, which are the
termination ﬁelds for the perforant path glutamatergic afferents
(Amaral and Witter 1989). All quantiﬁcations were done on micro-
graphs magniﬁed at 346 000.
Morphological Analysis
For the morphological analysis, astrocytic processes surrounding
asymmetric synapses between nerve terminals and dendritic spines
were identiﬁed according to published criteria (Peters et al. 1991;
Lehre and Danbolt 1998; Ventura and Harris 1999) and by their
concave shape and electron lucent appearance. Astrocytic processes
included in the analysis had cross-sectional diameters below 800 nm.
When the morphological analysis was performed in Lowicryl-embedded
tissue, astrocytic processes were also identiﬁed by labeling of EAAT2
(Chaudhry et al. 1995; Bezzi et al. 2004). Round and clear vesicular
structures in perisynaptic astrocytic processes were included in
the analysis if they had a diameter between 20 and 80 nm. The
perpendicular distance from the astrocytic plasma membrane to
the centers of synaptic-like microvesicles (SLMVs) in astrocytic
processes was analyzed and frequency histograms made. The number
of synaptic vesicles (SVs) in nerve terminals and SLMVs in astrocytic
processes were counted. The areas of nerve terminals and astrocytic
processes, as well as of clusters of SVs and SLMVs, were determined by
point counting using an overlay screen (Bergersen et al. 2008), and the
densities of SVs and SLMVs calculated. The cluster of SVs in nerve
terminals was recorded over an area made up by the presynaptic active
zone and perpendicular lines (distance of 100 nm) drawn from the end
of the active zone; and the cluster of SLMVs in astrocytic processes was
recorded over an area made by outlining of the grouped SLMVs
(exempliﬁed in Fig. 1 and Supplementary Fig. 2).
In addition, to investigate whether the SLMVs are randomly
distributed throughout the process or show a regularly spaced
organization, a plugin for ImageJ (http://rsb.info.nih.gov/ij/) was used
to outline the plasma membrane of the astrocytic process and record
the locations of the centers of SLMVs in the proﬁle. Random points
(similar numbers as the numbers of SLMVs in the proﬁles) were placed
over the astrocytic proﬁles 49 times in succession. Recorded
coordinates were submitted to a program written in Python (http://
www.python.org) for computation of clusters of SLMVs and random
points. An SLMV or a random point was deﬁned as belonging to
a cluster if their centers were situated <100 nm from the closest SLMV
or random point (see Supplementary Result 1). The distances between
the clusters of SLMVs and random points were calculated in the
following way: ﬁrst, perpendicular lines from the cluster centers were
drawn to the astrocytic plasma membrane. Then, the distances along
the plasma membrane between each SLMV and random point
intersection with the plasma membrane were calculated. The statistical
signiﬁcance of the difference between the observed and expected
(random points) distributions among bins was evaluated by the chi-
square test for known distributions (see Supplementary Result Fig. 1).
Glutamate and D-serine Quantiﬁcations
For immunogold quantiﬁcations of glutamate and D-serine, only the
astrocytic processes (identiﬁed by morphological criteria) with visible
EAAT2-positive plasma membranes that surrounded excitatory synap-
ses were included in the study. EAAT2 has been shown to be selectively
located in astrocytic membranes (Chaudhry et al. 1995). A synapse was
deﬁned as excitatory when it contained an asymmetric synaptic
specialization and/or high levels of glutamate in the presynaptic
terminal (above twice the glutamate levels in dendrites). Glutamate and
D-serine immunogold particles and grid points for area determination
(see below) were recorded over SLMVs in EAAT2-positive astrocytic
processes, over SVs in excitatory nerve terminals, and over cytoplasmic
matrix (areas free of vesicles and mitochondria in the astrocytes and
nerve terminals). SLMVs and SVs were included in the analysis if they
had a diameter ranging from 20 to 80 nm (this study, Gundersen et al.
1998; Bezzi et al. 2004). As the lateral resolution of the current
immunogold method (Supplementary Fig. 3) is similar to the diameter
of the SLMVs, the method cannot localize a gold particle to a single
vesicle. Thus, epitopes within SVs may be signaled by gold particles
outside the vesicles and vice versa. To bypass this problem, gold
particles were ascribed to the SLMVs and SVs if the particle centers
were inside the vesicles or located in the cytoplasmic matrix within
a 30 nm distance from the outer border of the vesicles. This is
a distance within which most of the immunogold particles are
expected to occur. Details of these criteria are given in Supplementary
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Figure 3 (see also Chaudhry et al. 1995; Matsubara et al. 1996). Using
this criterion, a gold particle was ascribed to a vesicle if the center
of the particle was located within an area deﬁned by a boundary drawn
30 nm from the vesicle membrane (see Supplementary Fig. 3). Particles
located outside of this ‘‘vesicle area’’ were assigned to the cytoplasmic
matrix. To correct for the contamination of the vesicle labeling with
the cytoplasmic matrix labeling, the gold particle densities recorded
over cytoplasmic matrix were subtracted from the gold particle
densities recorded for the vesicles. The areas of the proﬁles included
in the analysis were determined by point counting using an overlay
screen (Bergersen et al. 2008). The densities of glutamate and D-serine
immunogold particles (average number of gold particles/square
micrometer) in the different tissue proﬁles were calculated, and the
results statistically evaluated by a nonparametric test (Mann--Whitney
U, Statistica). To sum up, we counted the number of glutamate and
D-serine gold particles belonging to individual vesicles and estimated
the total area that individual vesicles occupy in a proﬁle, thus obtaining
a measure of the density of gold particles per vesicle area.
The spatial relationships between gold particles signaling: 1) D-serine
(10 nm) or glutamate (10 nm) and VGLUT1 (15 nm); 2) D-serine
(10 nm) and glutamate (15 nm); and 3) calreticulin (10 nm) or
caveolin-1 (10 nm) and VGLUT1 (15 nm) in morphologically identiﬁed
astrocytic processes and excitatory nerve terminals were determined
by a computer program (http://rsb.info.nih.gov/ij/). The intercenter
distances between the 10 and 15 nm gold particles were calculated, and
the distances were sorted into bins of 20 nm. The frequency
distributions were evaluated by a chi-squared test (Statistica).
The relationship between the density of glutamate and D-serine
immunogold particles and the concentration of ﬁxed glutamate and D-
serine in the tissue was close to linear, as assessed by simultaneously
processed test sections with conjugates containing known concen-
trations of glutamate (Ottersen 1989a) and D-serine (see Supplemen-
tary Fig. 4). Similar relationships between the density of gold particles
signaling glutamate and the concentration of glutamate in the test
conjugates as found in the present investigation have been described
previously (Ottersen 1989a; Bramham et al. 1990). The D-serine--graded
test conjugates were made as previously described for graded
D-aspartate sections (Gundersen et al. 1995). In brief, slabs of 7%
gelatin and 10% human serum albumin (HSA) with known areas were
incubated in 10% HSA at various concentrations of D-serine (0, 0.33, 1,
3, 9, and 27 mM) before immersing in the tissue ﬁxative (2.5%
glutaraldehyde and 1% formaldehyde) for 1 h. The ﬁxed blocks were
then embedded in Durcupan. The concentrations of D-serine in the
conjugate slabs after ﬁxation (but before embedding) were determined
by liquid scintillation counting using tracer amounts of D-3H-serine
(Perkin Elmer). Hence, the particle density in tissue compartments
could be compared with those over the different D-serine conjugates.
Results
Synaptic-Like Microvesicles
We analyzed astrocytes in the hippocampal dentate molecular
layer of adult rats. At ﬁrst, we used a preparation optimized for
morphologic visualization of membrane-bounded structures
(tissue ﬁxed with high glutaraldehyde concentration, postﬁxed
with osmium tetroxide, and embedded in epoxy resin) to
quantify vesicular organelles in delicate astrocytic processes
surrounding excitatory synapses. The perisynaptic astrocytic
processes (average cross-sectional diameters of 429 ± 195 nm
[standard deviation {SD}, n = 48]) were identiﬁed by their
concave shape and low electron density (Lehre and Danbolt
1998). Figure 1 shows that these processes contain vesicles
resembling SVs. They are small (average diameter of about 36
nm, Fig. 1c), clear, and round/oval, justifying the term SLMV
Figure 1. Astrocytic processes facing asymmetric synapses in the dentate molecular layer contain SLMVs. (a and b) Electron micrographs of osmicated tissue embedded in
epoxy resin showing astrocytic processes (Ast), containing small and clear SLMVs with an oval/round shape that are close to the plasma membrane. Insets: Higher magnification
of SLMVs (red arrowheads) and SVs (black arrowheads). In (b), red dotted lines highlight a small cluster of SLMVs (other examples in Supplementary Fig. 1). Symbols: Term,
nerve terminal; Sp, dendritic spines; stars, synaptic clefts. Scale bars: 100 and 50 nm in insets. (c) Comparative frequencies of SLMV and SV diameters. Diameters were sorted
into bins of 20 nm (columns, x axis) and the percentage of total calculated for each bin (y axis). The mean diameter ± SD of the SLMVs (36.6 ± 10.8 nm, n5 241 vesicles in 48
processes) and SV (39.2 ± 11.4 nm, 333 vesicles in 8 nerve terminals). (d) Histogram showing the frequency of SLMVs (indicated along y axis) related to their distance (nm)
from the astrocytic plasma membrane (indicated along x axis). The distances between the center of the vesicles and the astrocytic plasma membrane were put into bins of 50
nm. (e and f) Bar charts showing the vesicle density (average number of SLMVs and SVs/lm2 ± SD) either in the entire astrocytic process (n5 48) and nerve terminal (n5 18)
profiles or specifically in vesicle clusters in astrocytic processes (n 5 48) and in the synaptic vesicle pool located \100 nm from the nerve terminal active zone (n 5 18) (see
also Supplementary Fig. 1). *, the value for SV is significantly higher than the value for SLMV (P \ 0.01, Mann--Whitney U test, two tails).
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(Bezzi et al. 2004; Jourdain et al. 2007). The SLMVs were found
to be present in the majority (67%) of the observed processes,
with a nonrandom distribution throughout the cytoplasm. They
were situated in small clusters of 2--15 vesicles (Figs 1a,b and
2) and were preferentially located at or near the astrocytic
plasma membrane (maximal frequency within 50 nm from the
membrane, Fig. 1d). In proﬁles containing more than one
cluster, the average intergroup distance was 340 ± 209 nm (SD,
n = 350 clusters). The average density of SLMVs in an astrocytic
proﬁle was about one-tenth of the density of SVs in excitatory
terminals (Fig. 1e), but within the area delimiting an astrocytic
cluster, the density of SLMVs was about one-half of the density
of SVs located in proximity (within 100 nm) of the presynaptic
membrane active zone (Figs 1f and 2; for detailed quantitative
analysis of SLMVs in perisynaptic processes, see Supplementary
Result 1).
Quantitative Immunogold Cytochemistry
We then continued our investigations on tissue prepared for
optimal immunogold sensitivity (tissue treated with uranyl
acetate and embedded in Lowicryl). In this case, astrocytic
processes were identiﬁed and selected for analysis not only
according to the morphological criteria indicated above but
also based on the membrane labeling for the astrocytic
glutamate transporter EAAT2/GLT1. Small clusters of SLMVs
located at or near the astrocytic membrane (Supplementary
Fig. 2) were visible also in this preparation, and individual
vesicles could be reliably recognized (Supplementary Result 2),
even though their membranes were less distinct than the SV
membranes. We therefore tested whether SLMVs contain
glutamate and D-serine by use of speciﬁc antibodies against
the 2 amino acids. The protocol for attributing glutamate and
D-serine immunogold particles to vesicles or to the cytoplas-
mic matrix is given in Materials and Methods (section on
morphological and immunogold analysis). Using this approach,
we could show that astrocytic SLMVs contain immunogold
particles signaling glutamate and D-serine (Fig. 2). This
conclusion was reinforced by the observation that most of
the immunogold particles signaling glutamate and D-serine
were located <100 nm from the astrocytic plasma membrane
and followed the SLMV distribution (Supplementary Fig. 5).
The density of glutamate immunogold particles over the SLMVs
wasmuchhigher than the density in the cytoplasmicmatrix of the
astrocytes and only slightly lower than the density over SVs
in adjacent excitatory nerve terminals. The particle density in the
cytoplasmic matrix of the astrocytes was, in turn, lower than that
in the cytoplasmic matrix of nerve terminals (Fig. 2a--c). To assess
the degree of glutamate accumulation in the vesicles, we
calculated the ratio of glutamate labeling between the vesicles
and the cytoplasmicmatrix. This ratiowas higher between SLMV/
astrocytic cytoplasmic matrix than between SVs/terminal cyto-
plasmic matrix (22 vs. 6; see Supplementary Result 3 for a control
of the ﬁxation efﬁciencies of free amino acids at protein-rich
vs. nonprotein-rich sites in the tissue).
Figure 2. Glutamate and D-serine are located in SLMVs in astrocytic processes in the dentate molecular layers. (a--b and d--e) Electron micrographs showing examples of
glutamate (a--b) and D-serine (d--e) labeling (small gold particles) of SLMVs (some indicated by red arrowheads) in astrocytic processes (Ast) positive for EAAT2 (large gold
particles). Gold particles signaling glutamate are also located over synaptic vesicles (some indicated by black arrowheads) in asymmetric synapses (stars) between nerve
terminals (Term) and dendritic spines (Sp). Insets: higher magnification showing the similarities between SLMVs (red dotted arrows) and SVs (black dotted arrow). Note that the
astrocytic SLMVs are often localized in small clusters close to the plasma membrane. a--b show tissue fixed in low glutaraldehyde, while d--e show tissue fixed in high
glutaraldehyde. Scale bars: 100 and 50 nm in insets. m: mitochondria. (c and f) Immunogold quantification of glutamate (c) and D-serine (f) gold particles in astrocytic processes.
The bar charts show the mean number of glutamate and D-serine gold particles/lm2 ± SD in SLMVs and the cytoplasmic matrix of astrocytic processes (Acyt) in n5 3 animals.
In addition, we show the density of glutamate gold particles in nerve terminals over SVs and the cytoplasmic matrix (Tcyt). Background glutamate and D-serine labeling over
empty resin (0.9 and 0.8 gold particles/lm2, respectively) were subtracted. The numbers of astrocytic processes and nerve terminals included in the glutamate analysis from
each animal were 44--50 and 13--21, respectively, while the numbers of astrocytic processes included in the D-serine analysis from each animal were 25--28. *, the glutamate
values in SV and SLMV are significantly higher than the values in Tcyt and Acyt, respectively (P \ 0.001, Mann--Whitney U test, two tails). §, the glutamate value in SV is
significantly higher than the value in SLMV (P \ 0.05, Mann--Whitney U test, 2 tails). #, the D-serine value in SLMV is significantly higher than the value in Acyt (P \ 0.001,
Mann--Whitney U test, two tails).
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As previously reported, D-serine labeling was observed in
astrocytic processes (Schell et al. 1995; Williams et al. 2006)
(Fig. 2d,e). Gold particles representing D-serine were associ-
ated with the SLMVs rather than with the cytoplasmic matrix
(Fig. 2f). The ratio of D-serine gold particle density between
SLMV and cytoplasmic matrix of the astrocytes was 8,
suggesting a considerable accumulation of D-serine in the
SLMVs. In addition, nerve terminals exhibited a rather weak
D-serine signal with no clear association to vesicular structures
(Kartvelishvily et al. 2006) (for details of the intraterminal
distribution of D-serine, see Supplementary Result 4).
The approximate concentration of glutamate and D-serine
in the different tissue proﬁles was estimated by calibration
with known concentrations of glutamate and D-serine (see
Supplementary Fig. 4). The glutamate gold particle densities
corresponded to a concentration of glutamate of ~50--60 mM in
SLMVs and SVs and of ~2 and ~10 mM in the cytoplasmic matrix
of the astrocytes and the nerve terminals, respectively. For D-
serine, we estimated that the concentration of ﬁxed D-serine in
the SLMVs was ~10 mM, whereas the D-serine concentration in
the astrocyte cytoplasmic matrix was ~1 mM.
To investigate whether glutamate and D-serine are contained
in the same pool of SLMVs, we performed double labeling with
the glutamate and D-serine antibodies. In none of the investigated
astrocytic processes was there any clear evidence of colocaliza-
tion of the 2 amino acids in the same SLMV (Fig. 3a,e). Likewise,
colabelling with D-serine and VGLUT1 antibodies did not reveal
any clear colocalization (Fig. 3b,f), whereas, as expected, there
were several examples of glutamate and VGLUT1 gold particles
associated with the same SLMV as well as with SVs (Fig. 3c,g, and
h). It should, however, be noted that the D-serine and VGLUT1
antibodies produced a relatively low immunolabeling of SLMVs,
which could have led to an underestimation of D-serine/
glutamate and D-serine/VGLUT1 double labeling. Thus, we
cannot totally exclude a partial colocalization of D-serine and
glutamate in the same vesicle pool.
Exocytosis of SLMVs in astrocytes has been proposed to
occur upon Ca2
+
mobilization from the endoplasmic reticulum
(ER) (Marchaland et al. 2008). We checked the presence of ER
tubules in the perisynaptic astrocytic processes and their
spatial relation with SLMVs. Antibodies against the ER marker
calreticulin labeled elongated tubular structures, mostly in
Figure 3. SLMVs containing glutamate do not coincide with SLMVs containing D-serine: spatial association with ER in astrocytic processes. (a--c and h) Double labeling of
D-serine (small gold particles)/glutamate (large gold particles) (a), D-serine (small gold particles)/VGLUT1 (large gold particles) (b), glutamate (small gold particles)/VGLUT1 (large
gold particles) (c), and calreticulin (small gold particles)/VGLUT1 (large gold particles) (d) at excitatory synapses between nerve terminals (Term) and postsynaptic spines (Sp)
surrounded by astrocytic processes (Ast) in the dentate molecular layer. Short arrows indicate D-serine in a--b, glutamate in c, and calreticulin in h. Long arrows indicate
glutamate in a and VGLUT1 in b--c and h. The SLMVs are indicated by red arrowheads. The insets show higher magnification of SLMVs positive for either glutamate or D-serine
(a--b), for both glutamate and VGLUT1 (c), and for VGLUT1 (h). m 5 mitochondria. Scale bars: 100 and 50 nm in insets. (d--g and i) Distances separating gold particles signaling:
D-serine/glutamate (d) and D-serine/VGLUT1 (e) in astrocytic processes; glutamate/VGLUT1 in astrocytic processes (f) and nerve terminals (g); calreticulin/VGLUT1 in astrocytic
processes (i). Distances are put into bins of 20 nm (columns, x axis), and the percent of total in each bin is given along the y axis. Because of the diameter of the vesicle (30--40
nm) and the lateral resolution of the immunogold method (~30 nm), gold particles signaling 2 different epitopes in the same vesicle could be separated by a distance of up to
about 90--100 nm. Most of the D-serine/glutamate or D-serine/VGLUT1 and calreticulin/VGLUT1 gold particles do not signal epitopes in the same vesicular membrane, while most
of the gold particles representing glutamate/VGLUT1 belong to the same vesicle. The distribution of D-serine/glutamate, D-serine/VGLUT1, and calreticulin/VGLUT1 intercenter
distances was significantly different from the glutamate/VGLUT1 distribution (P \ 0.01, chi-squared test). These quantifications were done in 25 astrocytic processes positive for
D-serine/glutamate, in 25 astrocytic processes positive for D-serine/VGLUT1, in 23 astrocytic processes and 27 nerve terminals positive for glutamate/VGLUT1, and in 20
astrocytic processes positive for calreticulin/VGLUT1 in one animal, but similar results were obtained in 2 other animals.
Glutamate and D-serine in Astrocytes d Bergersen et al.1694
neuronal dendritic proﬁles, but also in astrocytic processes
(Fig. 3d,i; Supplementary Fig. 6). VGLUT1 and calreticulin
double labeling suggest that the astrocytic processes are
equipped with ER located close to (within 100--200 nm), but
not overlapping with, glutamate-containing SLMVs (Fig. 3d).
Astrocytic processes were also endowed with membrane-
bounded structures labeled for caveolin-1. Double labeling for
VGLUT1 and caveolin-1 (Supplementary Fig. 7) showed no
signiﬁcant colocalization, suggesting that astrocytic processes
contain several pools of vesicle-like organelles that may serve
separate functions, such as storage of transmitters, storage of
Ca2
+
, and caveola-mediated endocytosis.
Discussion
The present immunogold data from perisynaptic astrocytic
processes provide the ﬁrst direct evidence that the putative
gliotransmitters glutamate and D-serine are stored in astrocytic
SLMVs in situ in the adult brain. The presence in the ﬁne
perisynaptic processes of clusters of transmitter-containing
SLMVs at or near the astrocytic membrane, together with
spatially related ER tubules, is a prerequisite for precise
astrocyte-to-neuron communication. Indeed, these ultrastruc-
tural observations support functional data showing that
activation of endogenous G protein-coupled receptors on
astrocytes induces glutamate receptor--dependent and tetanus
toxin sensitive presynaptic modulation in situ (Jourdain et al.
2007; Perea and Araque 2007) and that astrocytes display
a glutamate exocytosis process tightly regulated by TNF-a
(Santello et al. 2011). Moreover, our data are in line with the
recent observation that selective dialysis of tetanus toxin in
astrocytes prevents LTP induction at neighboring synapses by
blocking D-serine release (Henneberger et al. 2010). Tetanus
toxin is an exocytosis blocker acting on VAMP3/cellubrevin,
which is expressed in SLMVs (Bezzi et al. 2004). The present
and previous observations in support of astrocytic transmitter
exocytosis were made in the hippocampus. However, the
conclusions are likely to be more generally valid as VGLUT1 is
closely associated with SLMVs also in several other brain
regions, including frontal cortex and striatum (L Ormel, LH
Bergersen, V Gundersen, unpublished data). It should also be
noted that in freshly isolated astrocytes, recent observations
show that, unlike lysosomal vesicles, small vesicles in astrocytes
exocytose glutamate in a vesicular glutamate transporter--
dependent manner (Liu et al. 2011), which is in strong support
of our data on glutamate localization in astrocytic SLMVs.
Our present data also reveal an important number of
similarities between glutamate-containing SLMVs in astrocytic
processes and SVs in excitatory nerve terminals. Not only are
SLMVs similar to SVs in size and shape, as previously reported
(Bezzi et al. 2004), but also in glutamate content, which is here
estimated in astrocytes for the ﬁrst time, and in localization with
respect to the astrocytic plasma membrane. Thus, most
astrocytic SLMVs are as close to the plasma membrane as the
readily releasable pool of SVs in nerve terminals (Gitler et al.
2004; Owe et al. 2009), consistent with the possibility that
a proportion of astrocytic SLMVs is docked and competent for
fast fusion in response to stimuli. The organization of SLMVs in
astrocytic processes seems different from the grouping of a large
SV population in nerve terminal structures. In particular, in the
nerve terminals, there appears to be an accumulation of distinct
pools of SVs, with a large reserve pool (80--90% of the vesicles)
mostly located in the core region of the terminal and linked to
the cytoskeleton by synapsin--actin interactions (Owe et al.
2009). Interestingly, hippocampal excitatory nerve terminals of
synapsin-lacking mice display selective reduction in the density
of this large pool, whereas the small readily releasable/recycling
pool ( <100 nm from the plasma membrane) remains largely
intact (Gitler et al. 2004; Owe et al. 2009). The presence of
distinct pools is not apparent in astrocytes, as SLMVs are all
regrouped within 100 nm from the membrane, suggesting that
astrocytes lack a deﬁned reserve pool. This hypothesis seems
plausible because mobilization of the reserve pool at synapses is
triggered only during high-frequency neuronal activity. In
astrocytes, exocytosis of SLMVs is evoked by activation of G
protein--coupled receptors and even if the stimulus--secretion
coupling can occur within 50--100 ms (Bezzi et al. 2004;
Domercq et al. 2006; Marchaland et al. 2008), this signaling
mode is not tailored for high-frequency encoding. Lack of a large
reserve pool would explain both the signiﬁcantly lower number
of vesicles found in astrocytic processes compared with nerve
terminals and their low electron density due to reduced protein--
protein interactions. Moreover, we found that astrocytic pro-
cesses are equipped with ER located close to glutamate-
containing SLMVs. This subcellular arrangement could constitute
a functional nanodomain in which local increases in Ca2
+
concentration from the internal stores trigger release of
glutamate from SLMVs (Marchaland et al. 2008). Ca2
+
micro-
domains have been observed in astrocyte cultures (Lee et al.
2006; Shigetomi et al. 2010), and in addition to controlling
transmitter release, it has been proposed that such domains may
be involved in local volume regulation in astrocytes (Akita and
Okada 2011). In the cerebellum, neuronal stimulation has been
shown to trigger Ca2
+
increase in Bergmann glial cells at distinct
microdomains (Grosche et al. 1999). Moreover, very recent
evidence in the adult dentate gyrus shows that astrocytic
processes respond to local synaptic events with highly conﬁned
Ca2
+
elevations that, in turn, participate to the control of
transmitter release at local synapses (Di Castro et al. 2011),
strongly supporting the view that these astrocyte domains
represent local sites at which astrocyte-neuron signaling occurs.
The present study provides estimated values of the vesicular
and cytosolic glutamate concentrations in nerve terminals and
astrocytes. The values in SVs and in the cytoplasmic matrix of
nerve terminals are in good agreement with previous estimates
(Burger et al. 1989; Shupliakov et al. 1992). The glutamate
concentration that we ﬁnd in the cytosolic matrix of astrocytic
processes is in the lower millimolar range, a concentration which
can sustain glutamate uptake into SLMVs according to the
reported Km of VGLUT-mediated vesicular uptake (Fremeau
et al. 2004). As the glutamate ratios between vesicles and cytosolic
matrix were different in nerve terminals and astrocytes, there may
be some differences in the mechanisms regulating the ﬁlling of
SLMVs and SVs. Indeed, mechanisms similar to those discovered to
operate in dopaminergic (Brunk et al. 2006) and cholinergic (Gras
et al. 2008) vesicles could contribute to regulate glutamate uptake
into astrocytic SLMVs. An intriguing aspect of exocytosis
regulation is whether VGLUTs are inserted into plasma mem-
branes to function as phosphate transporters. However, we could
not observe any immunogold signal for VGLUT1 in plasma
membranes, neither in astrocytes nor in nerve terminals (LH
Bergersen, V Gundersen, unpublished data).
Our ﬁndings regarding D-serine are intriguing. The labeling
pattern in astrocytic processes strongly suggests a vesicular
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localization of D-serine (see also Williams et al. 2006). However,
the VGLUTs do not carry D-serine, suggesting that there is
a vesicular transporter for D-serine that remains to be identiﬁed.
D-serine is present in a population of astrocytic SLMVs
structurally indistinguishable from the one storing glutamate.
However, SLMVs containing D-serine and glutamate do not
appear to overlap to any considerable extent. Yet, both
glutamate-containing and D-serine--containing SLMVs are pres-
ent in the same very ﬁne astrocytic processes and are in the
position of discharging their amino acid content into the
perisynaptic area surrounding excitatory synapses on granule
cell dendrites. It has been shown that glutamate released by
exocytosis from astrocytes produces presynaptic NMDA re-
ceptor responses, which in turn strengthen the excitatory
synaptic response at granule cell synapses (Jourdain et al. 2007,
Santello et al. 2011). In addition, our results suggest that
exocytosis underlies the astrocytic glutamate release detected
by electrophysiology in stratum radiatum of CA1 hippocampus
(Kang et al. 1998; Fiacco et al. 2004; Andersson et al. 2007;
Andersson and Hanse 2010) and the cortex (Wirkner et al.
2007). There are several lines of evidence suggesting that release
of D-serine from astrocytes can regulate neuronal NMDA
receptors. In intact brain tissue, it is known that astrocytic
D-serine release controls the level of activation of synaptic
NMDA receptors and thereby long-term synaptic signaling in the
hypothalamus (Panatier et al. 2006) and CA1 hippocampus
(Henneberger et al. 2010). Likewise, in the retina, it is known
that glial cell--derived D-serine can enhance NMDA receptor
responses (Stevens et al. 2003). Using a combination of neurons
and astrocytes in culture and hippocampal slices, Yang et al.
(2003) found that D-serine released from astrocytes enhanced
neuronal NMDA receptor currents and triggered LTP. Interest-
ingly, the release of D-serine from astrocytes can be subjected to
regulation, for example, by ephrinBs (Zhuang et al. 2010).
In conclusion, we propose that the joint or separate release
of glutamate and D-serine from astrocytes could provide
a sophisticated control of the activity of neuronal NMDA
receptor populations.
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